Tylenol recall expands again

The drugmaker has added more lots of over-the-counter drugs to a recall that began in January.


An ongoing recall by the maker of Tylenol and other medications was once again expanded on Thursday, according to the U.S. Food and Drug Administration.

McNeil Consumer Healthcare is recalling 21 lots of over-the-counter medicines associated with a recall that began Jan. 15. Consumer complaints of a musty or moldy odor in some McNeil medications was traced to the presence of a chemical called 2,4,6-tribromoanisole, or TBA.

A review determined the chemical was produced by some packaging materials that had been shipped and stored on the same type of wooden pallet that was tied to the presence of TBA in earlier recalled lots. The risk of serious adverse medical events is remote, according to officials. All lots involved in the recall were produced before the Jan. 15 recall, after which McNeil stopped accepting shipments of materials from its suppliers on that type of pallet.

The newest version of the recall involves over-the-counter medicines sold in the United States, Fiji, Guatemala, Dominican Republic, Puerto Rico, Trinidad and Tobago, and Jamaica. Recalled products include Benadryl Allergy Ultratab, Motrin IB, Tylenol Extra Strenth and Tylenol PM and Children's Tylenol Metalways bubblegum flavor. A complete list can be found at www.fda.gov/Safety/Recalls/ucm218437.htm.

Consumers who purchased product from the lots included in this recall should stop using it and contact McNeil Consumer Healthcare for instructions on a refund or replacement at www.mcneilproductrecall.com or 888-222-6036.

The product lot numbers for the recalled products can be found on the side of the bottle label.


Use the comment form below to begin a discussion about this content.

Sign in to comment

Click here to sign in